Nicola Bevan

807 total citations
28 papers, 489 citations indexed

About

Nicola Bevan is a scholar working on Molecular Biology, Cellular and Molecular Neuroscience and Oncology. According to data from OpenAlex, Nicola Bevan has authored 28 papers receiving a total of 489 indexed citations (citations by other indexed papers that have themselves been cited), including 20 papers in Molecular Biology, 9 papers in Cellular and Molecular Neuroscience and 6 papers in Oncology. Recurrent topics in Nicola Bevan's work include Receptor Mechanisms and Signaling (10 papers), Neuropeptides and Animal Physiology (5 papers) and Viral Infectious Diseases and Gene Expression in Insects (4 papers). Nicola Bevan is often cited by papers focused on Receptor Mechanisms and Signaling (10 papers), Neuropeptides and Animal Physiology (5 papers) and Viral Infectious Diseases and Gene Expression in Insects (4 papers). Nicola Bevan collaborates with scholars based in United Kingdom, Germany and United States. Nicola Bevan's co-authors include Stephen Edward Rees, Graeme Milligan, Sheraz Ahmed, Andreas Dengel, Christoffer Edlund, Johan Trygg, Rickard Sjögren, Nabeel Khalid, Timothy R. Jackson and Timothy Dale and has published in prestigious journals such as The Journal of Immunology, Nature Methods and Cancer Research.

In The Last Decade

Nicola Bevan

26 papers receiving 478 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Nicola Bevan United Kingdom 13 299 153 104 51 51 28 489
Sreetama Basu France 11 146 0.5× 81 0.5× 77 0.7× 33 0.6× 108 2.1× 19 430
Raik Böckelmann Germany 10 324 1.1× 47 0.3× 168 1.6× 7 0.1× 56 1.1× 18 605
Walid M. Abdelmoula United States 17 464 1.6× 23 0.2× 112 1.1× 12 0.2× 57 1.1× 23 806
Linjing Fang United States 8 215 0.7× 10 0.1× 81 0.8× 44 0.9× 39 0.8× 10 450
Bence Szalai Hungary 12 557 1.9× 99 0.6× 63 0.6× 3 0.1× 41 0.8× 21 975
Elizabeth McWhinnie United States 8 585 2.0× 92 0.6× 149 1.4× 39 0.8× 41 0.8× 10 792
Lixin Liu China 13 370 1.2× 36 0.2× 109 1.0× 13 0.3× 48 0.9× 23 661
Zhouyi Rong China 8 129 0.4× 39 0.3× 39 0.4× 3 0.1× 99 1.9× 12 463
Thomas P. Hasaka United States 10 289 1.0× 66 0.4× 140 1.3× 53 1.0× 20 0.4× 11 544
Melissa Moran United States 7 49 0.2× 35 0.2× 29 0.3× 13 0.3× 41 0.8× 12 287

Countries citing papers authored by Nicola Bevan

Since Specialization
Citations

This map shows the geographic impact of Nicola Bevan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Nicola Bevan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Nicola Bevan more than expected).

Fields of papers citing papers by Nicola Bevan

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Nicola Bevan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Nicola Bevan. The network helps show where Nicola Bevan may publish in the future.

Co-authorship network of co-authors of Nicola Bevan

This figure shows the co-authorship network connecting the top 25 collaborators of Nicola Bevan. A scholar is included among the top collaborators of Nicola Bevan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Nicola Bevan. Nicola Bevan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Bevan, Nicola, et al.. (2025). Optimising and adapting perfusion feeds in serum-free medium to intensify CAR-T cell expansion in stirred-tank bioreactors. Frontiers in Bioengineering and Biotechnology. 13. 1593895–1593895. 2 indexed citations
2.
Bevan, Nicola, et al.. (2025). Abstract 2829: Multifaceted characterization of ferroptosis using live-cell imaging and AI-driven analysis. Cancer Research. 85(8_Supplement_1). 2829–2829.
3.
Bevan, Nicola, et al.. (2025). Establishing a scalable perfusion strategy for the manufacture of CAR‐T cells in stirred‐tank bioreactors using a quality‐by‐design approach. Bioengineering & Translational Medicine. 10(3). e10753–e10753. 3 indexed citations
4.
5.
Edlund, Christoffer, Timothy R. Jackson, Nabeel Khalid, et al.. (2021). LIVECell—A large-scale dataset for label-free live cell segmentation. Nature Methods. 18(9). 1038–1045. 135 indexed citations
6.
Bevan, Nicola, et al.. (2020). Covid-19: virtual occupational skin health clinics for healthcare workers. BMJ. m2281–m2281. 12 indexed citations
7.
Bevan, Nicola, Paul W. Hastwell, Patrick M. Eidam, et al.. (2012). The BlueScreen-384 Assay as an Indicator of Genotoxic Hazard Potential in Early-Stage Drug Discovery. SLAS DISCOVERY. 18(4). 441–452. 12 indexed citations
8.
Bevan, Nicola, Amanda Emmons, Peter J. Gough, et al.. (2012). In vivo activity of an azole series of CCR2 antagonists. Bioorganic & Medicinal Chemistry Letters. 22(23). 7252–7255. 1 indexed citations
9.
Procopiou, Panayiotis A., Victoria J. Barrett, Nicola Bevan, et al.. (2011). The discovery of long-acting saligenin β2 adrenergic receptor agonists incorporating hydantoin or uracil rings. Bioorganic & Medicinal Chemistry. 19(14). 4192–4201. 13 indexed citations
11.
Adam, Lynda, et al.. (2005). Subcellular distribution of GABAB receptor homo- and hetero-dimers. Biochemical Journal. 388(1). 47–55. 43 indexed citations
12.
Bevan, Nicola & Stephen Edward Rees. (2005). Pharmaceutical Applications of GFP and RCFP. Methods of biochemical analysis. 47. 361–389. 3 indexed citations
13.
Ramsay, Douglas, et al.. (2001). Detection of receptor ligands by monitoring selective stabilization of aRenillaluciferase‐tagged, constitutively active mutant, G‐protein‐coupled receptor. British Journal of Pharmacology. 133(2). 315–323. 18 indexed citations
14.
Stevens, Patricia A., Nicola Bevan, Stephen Edward Rees, & Graeme Milligan. (2000). Resolution of Inverse Agonist-Induced Up-Regulation from Constitutive Activity of Mutants of the α1b-Adrenoceptor. Molecular Pharmacology. 58(2). 438–448. 25 indexed citations
15.
Stevens, Patricia A., Nicola Bevan, Stephen Edward Rees, & Graeme Milligan. (2000). Resolution of Inverse Agonist-Induced Up-Regulation from Constitutive Activity of Mutants of the α1b-Adrenoceptor. Molecular Pharmacology. 58(2). 438–448. 9 indexed citations
17.
McLean, Alison J., Nicola Bevan, Stephen Edward Rees, & Graeme Milligan. (1999). Visualizing Differences in Ligand Regulation of Wild-Type and Constitutively Active Mutant β2-Adrenoceptor-Green Fluorescent Protein Fusion Proteins. Molecular Pharmacology. 56(6). 1182–1191. 34 indexed citations
18.
McLean, Alison J., et al.. (1999). Visualizing Differences in Ligand Regulation of Wild-Type and Constitutively Active Mutant β2-Adrenoceptor-Green Fluorescent Protein Fusion Proteins. Molecular Pharmacology. 56(6). 1182–1191. 7 indexed citations
19.
Latif, M.L., et al.. (1998). Influence of receptor number on the stimulation by salmeterol of gene transcription in CHO‐K1 cells transfected with the human β2‐adrenoceptor. British Journal of Pharmacology. 125(4). 717–726. 40 indexed citations
20.
Bevan, Nicola, et al.. (1998). Nociception activates Elk-1 and Sap 1a following expression of the ORL 1 receptor in Chinese hamster ovary cells. Neuroreport. 9(12). 2703–2708. 17 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026